![](/images/graphics-bg.png)
Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab
المؤلفون المشاركون
Nolan, John M.
Meagher, Katherine A.
Stack, Jim
Sabour-Pickett, Sarah
Beatty, Stephen
Pesudovs, Konrad
Loughman, James
المصدر
العدد
المجلد 2013، العدد 2013 (31 ديسمبر/كانون الأول 2013)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2013-02-21
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Purpose.
To assess visual function and its response to serial intravitreal ranibizumab (Lucentis, Genentech) in patients with neovascular age-related macular degeneration (nv-AMD).
Methods.
Forty-seven eyes of 47 patients with nv-AMD, and corrected distance visual acuity (CDVA) logMAR 0.7 or better, undergoing intravitreal injections of ranibizumab, were enrolled into this prospective study.
Visual function was assessed using a range of psychophysical tests, while mean foveal thickness (MFT) was determined by optical coherence tomography (OCT).
Results.
Group mean (±sd) MFT reduced significantly from baseline (233 (±59)) to exit (205 (±40)) (P=0.001).
CDVA exhibited no change between baseline and exit visits (P=0.48 and P=0.31, resp.).
Measures of visual function that did exhibit statistically significant improvements (P<0.05 for all) included reading acuity, reading speed, mesopic and photopic contrast sensitivity (CS), mesopic and photopic glare disability (GD), and retinotopic ocular sensitivity (ROS) at all eccentricities.
Conclusion.
Eyes with nv-AMD undergoing intravitreal ranibizumab injections exhibit improvements in many parameters of visual function.
Outcome measures other than CDVA, such as CS, GD, and ROS, should not only be considered in the design of studies investigating nv-AMD, but also in treatment and retreatment strategies for patients with the condition.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Sabour-Pickett, Sarah& Loughman, James& Nolan, John M.& Stack, Jim& Meagher, Katherine A.& Beatty, Stephen…[et al.]. 2013. Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab. Journal of Ophthalmology،Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-458919
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Meagher, Katherine A.…[et al.]. Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab. Journal of Ophthalmology No. 2013 (2013), pp.1-7.
https://search.emarefa.net/detail/BIM-458919
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Sabour-Pickett, Sarah& Loughman, James& Nolan, John M.& Stack, Jim& Meagher, Katherine A.& Beatty, Stephen…[et al.]. Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab. Journal of Ophthalmology. 2013. Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-458919
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-458919
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)